|
CAHR Market Access 201 (MA201)CAHR's industry-renowned Market Access 201 provides an advanced perspective of the various fields of activity involved in market access, from clinical trials to budget impact analysis and government relations. Market Access 201 expands upon the Market Access 101 course information and takes its ideas further, providing context and insight to better understand the issues facing market access professionals. Upcoming: Market Access 201 Virtual Live Event
Limited number of special discounts available to patient groups and students. Please contact the CAHR office for information. The only constant in life is change, but this moment feels especially transformative for Canadian healthcare generally, and particularly for market access. As we scramble to make sense of the pandemic and plan for an eventual return to normal, transformative new medicines are coming to market, often with significant information demands and potentially requiring additional investments in infrastructure. These new treatments may also force us to rethink the nature of evidence, with a greater emphasis on life-cycle management and health technology management. Our faculty will discuss the implications of these and other challenges facing market access professionals and provide insights and direction for navigating the evolving frontier of market access.Market Access 201 is the second component required to obtain your Certified Market Access Professional (CMAP) Certification (learn more about CMAP here). Join your industry colleagues for a virtual learning journey. Register now for CAHR's Virtual MA 201 live two half day event on Tuesday, September 21st and Wednesday September 22nd, 2022 |
The Canadian Association for Healthcare Reimbursement 250 Consumers Road, Suite 301, Toronto, ON, M2J 4V6 F: 416.495.8723 | Phone 416.494.1440 X 222 | Email: info@cahr-acrss.ca
|